Company / Current Assets
Amneal Pharmaceuticals, Inc. Current Assets History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.9B
FY2025
5-year range
$1.4B / $1.9B
FY2021-FY2025
Trend
+20.4%
vs FY2024
Sector context
#33 of 213
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s current assets of $1.9B is higher than 85% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 9 years, ranging from $772M in FY2017 to $1.9B in FY2025.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +4.3%. Top quartile in the Health Care sector.
Improved from $1.4B to $1.9B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +10.6%
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Sector benchmark
-24.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.3%, indicating consistent growth.
- In FY2025, current assets increased 20.4% year-over-year.
- Ranks #33 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | +20.4% |
| FY2024 | $1.6B | +15.2% |
| FY2023 | $1.4B | -2.4% |
| FY2022 | $1.4B | -7.1% |
| FY2021 | $1.5B | -2.0% |
| FY2020 | $1.6B | +28.2% |
| FY2019 | $1.2B | -5.9% |
| FY2018 | $1.3B | +66.7% |
| FY2017 | $771.9M | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026